Sort
21,453 grants matching “tuberculosis”
NORTH DAKOTA TUBERCULOSIS ELIMINATION AND LABORATORY
$174,429Lindsey Vanderbusch · North Dakota State Department Of Health · U52 · FY2015 · PS
Identifying patients at risk of post-tuberculosis lung disease using novel cough and adherence predictors
$174,420Sophie Huddart · University Of California, San Francisco · K01 · FY2023 · HL
Identifying patients at risk of post-tuberculosis lung disease using novel cough and adherence predictors
$174,420Sophie Huddart · University Of California, San Francisco · K01 · FY2024 · HL
Identifying patients at risk of post-tuberculosis lung disease using novel cough and adherence predictors
$174,420Sophie Huddart · University Of California, San Francisco · K01 · FY2025 · HL
The Phosphatidylethanol (PEth) Results Communication (PERC) Study
$174,240Judith Alissa Hahn · University Of California, San Francisco · R34 · FY2025 · AA
Generation and persistence of CD4 memory subsets
$174,163Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · AI
Pulmonary Pathogen Defense Mechanisms
$174,152Case Western Reserve University · T32 · FY2004 · HL
Diversity and function of mononuclear phagocytes in the lung driven by mycobacterium tuberculosis infection
$174,150Beth S Zha · University Of California, San Francisco · K08 · FY2023 · HL
Diversity and function of mononuclear phagocytes in the lung driven by mycobacterium tuberculosis infection
$174,150Beth S Zha · University Of California, San Francisco · K08 · FY2022 · HL
Role of FHL-mediated formate metabolism in Mycobacterium tuberculosis persistence
$174,033Thomas C. Zahrt · Medical College Of Wisconsin · R21 · FY2013 · AI
Research Network for Drug-Induced Liver Disease
$174,000University Of Connecticut Sch Of Med/Dnt · U01 · FY2005 · DK
Research Network for Drug-Induced Liver Disease
$174,000Herbert L Bonkovsky · University Of Connecticut Sch Of Med/Dnt · U01 · FY2006 · DK
Use of Transfer Factor as a Novel Immune Therapeutic
$173,966Ian Myles · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Using Social Network Analysis to Guide Interview Structure during Tuberculosis-Re
$173,844Paul Anthony Fishwick · University Of Florida · R21 · FY2011 · HL
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
$173,842Neel Rajnikant Gandhi · Emory University · K24 · FY2014 · AI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
$173,842Neel Rajnikant Gandhi · Emory University · K24 · FY2015 · AI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
$173,842Neel Rajnikant Gandhi · Emory University · K24 · FY2016 · AI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
$173,842Neel Rajnikant Gandhi · Emory University · K24 · FY2018 · AI
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
$173,842Neel Rajnikant Gandhi · Emory University · K24 · FY2017 · AI
MONOCYTE RECRUITMENT IN PLEUROPULMONARY TB IN AIDS
$173,832University Of Florida · R01 · FY2003 · AI
Basic Science Core - Biosafety & Biocontainment Core (BBC)
$173,793Jordi B Torrelles · Texas Biomedical Research Institute · P30 · FY2023 · AI
HARLEM AIDS TREATMENT GROUP-'CPCRA'
$173,572Columbia University Health Sciences · U01 · FY2004 · AI
Strengthening Families Living with HIV in Kenya
$173,551Michael Goodman · University Of Texas Med Br Galveston · K01 · FY2024 · MH
Calanolides as tools to find new drug targets for Mycobacterium tuberculosis
$173,528Selin S Somersan-Karakaya · Weill Medical Coll Of Cornell Univ · K08 · FY2014 · AI
Synthesis and Studies of a New Family of Antibiotics
$173,486James S Nowick · University Of California-Irvine · R21 · FY2017 · AI